Search Results - "Talks JS"

Six-Year Outcomes in Subjects with Polypoidal Choroidal Vasculopathy in the PLANET Study.

Authors: Teo, Kelvin Yi Chong Yoon, Young Hee Honda, Shigeru et al.

Source: Ophthalmology & Therapy. Jun2026, Vol. 15 Issue 6, p1907-1924. 18p.

Neovascular age-related macular degeneration management – Beyond anti-VEGF.

Authors: Ayachit, Apoorva Rao, Shailesh Eqbal, Shadma et al.

Source: Indian Journal of Ophthalmology. May2026, Vol. 74 Issue 5, p653-660. 8p.

Beyond Cost: Faricimab as a Driver of Service Efficiency and Quality in Neovascular Age-Related Macular Degeneration Care.

Authors: Gil-Rojas, Yaneth Nicholson, Luke Eymere, Sebastien et al.

Source: Ophthalmology & Therapy. May2026, Vol. 15 Issue 5, p1647-1670. 24p.

Visual Acuity and Intraretinal Fluid as Predictive Factors for Legal Blindness and Macular Atrophy in Neovascular AMD Eyes Treated with Anti-VEGF: A Swedish Real-World Study.

Authors: Wickman, Isac Huzevkova, Ivana Schroeder, Marion et al.

Source: Clinical Ophthalmology. Apr2026, Vol. 20, p1-12. 12p.

Geometry-Based Intravitreal Pharmacokinetics: A Theoretical Pharmacokinetic Modeling Study Using Triamcinolone Acetonide and Vancomycin as Representative Intravitreal Agents.

Authors: Borkenstein, Andreas F Borkenstein, Eva-Maria Lira, Rodrigo Pessoa Cavalcanti

Source: Clinical Ophthalmology. Mar2026, Vol. 20, p1-14. 14p.

Treatment Regimens with Ranibizumab in Neovascular Age-Related Macular Degeneration: Real-World Results from the PACIFIC Study.

Authors: Lorenz, Katrin Haritoglou, Christos Barthelmes, Daniel et al.

Source: Clinical Ophthalmology. Aug2025, Vol. 19, p2927-2937. 11p.

Creation of a neovascular age‐related macular degeneration national database using a web‐based platform: Fight Retinal Blindness Spain. Report 1: Visual outcomes.

Authors: Zarranz‐Ventura, Javier Parrado‐Carrillo, Alba Nguyen, Vuong et al.

Source: Clinical & Experimental Ophthalmology. Apr2022, Vol. 50 Issue 3, p312-324. 13p.

Early-Phase Perceptions of COVID-19's Impact on Ophthalmology Practice Patterns: A Survey from the Pan-American Association of Ophthalmology.

Authors: Bonilla-Escobar, Francisco Javier Sánchez-Cano, Daniel Lasave, Andres F et al.

Source: Clinical Ophthalmology. Oct2023, Vol. 17, p3249-3259. 11p.

Rapid Effects on Anatomical and Functional Outcomes following Upload with Faricimab in Treatment-Naïve nAMD: German Single-Center Study 45DRY.

Authors: Haase, Maximilian Wittenborn, Esther

Source: Ophthalmology & Therapy. Jun2026, Vol. 15 Issue 6, p1955-1971. 17p.

Anti-vascular endothelial growth factors in retinal and choroidal diseases – Present landscape.

Authors: Kannan, Naresh B Vallinayagam, Muthukrishnan Rishitha, Konduru et al.

Source: Indian Journal of Ophthalmology. May2026, Vol. 74 Issue 5, p724-734. 11p.

The I-OPTA Questionnaire: A National Assessment of Patients with Neovascular Age-Related Macular Degeneration.

Authors: Thinggaard, Benjamin Sommer Hansen, Kasper Dinesen, Freja et al.

Source: Ophthalmology & Therapy. Dec2024, Vol. 13 Issue 12, p3035-3046. 12p.

Expert Panel Consensus for Optimizing Outcomes in Neovascular Age-Related Macular Degeneration in the Context of Suboptimal Response to a Biosimilar: The Role of Aflibercept.

Authors: Narendran, Nirodhini Bailey, Clare Downey, Louise et al.

Source: Clinical Ophthalmology. Nov2024, Vol. 18, p3133-3142. 10p.

Real-World Intravitreal Aflibercept 2 mg Treatment of Macular Oedema Secondary to Retinal Vein Occlusion in Italy: 24-Month Results from the AURIGA Observational Study.

Authors: Grassi, Maria Oliva Russo, Andrea Vadalà, Maria et al.

Source: Ophthalmologica. 2025, Vol. 248 Issue 4, p270-283. 14p.

Macular hole surgery in times of the COVID-19 pandemic.

Authors: Bleidißel, Nathalie Klaas, Julian Maier, Mathias

Source: Scientific Reports. 4/13/2025, Vol. 15 Issue 1, p1-9. 9p.

Targeted Therapy on Age-Related Macular Degeneration.

Authors: Sireesha, Vankodoth Ramya, Kaluvala Nikshitha, Manne et al.

Source: TNOA Journal of Ophthalmic Science & Research. Oct-Dec2024, Vol. 62 Issue 4, p397-403. 7p.

Short-Term Safety and Efficacy of Intravitreal Brolucizumab Injections for Neovascular Age-Related Macular Degeneration: A Multicenter Retrospective Real-World Study.

Authors: Kim, Dong Ju Jin, Ki Won Han, Jeong Mo et al.

Source: Ophthalmologica. 2023, Vol. 246 Issue 3/4, p192-202. 11p.

تأثیر استازولاماید بر فشار داخل چشم پس از تزریق داخل زجاجیه بواسيزوماب، تریامسینولون استوناید و ترکیب دو دارو.

Alternate Title: Effect of Acetazolamide on intraocular pressure after intravitreal injections of Bevacizumab, Triamcinolone Acetonide and combination of Bevacizumab - Triamcinolone Acetonide.

Authors: احسان نامور محمد کریم جوهری محمد حسین نوروزز

Source: Pars Journal of Medical Sciences. Fall2025, Vol. 23 Issue 3, p31-37. 7p.

The Reinforced Treat-and-Extend Protocol for Exudative Age-Related Macular Degeneration: Retrospective Assessment of 24-Month Real-World Outcomes in France.

Authors: Roubelat, François-Philippe Barioulet, Lisa Varenne, Fanny et al.

Source: Ophthalmology & Therapy. Jun2024, Vol. 13 Issue 6, p1647-1667. 21p.

Scoping review of the recommendations and guidance for improving the quality of rare disease registries.

Authors: Tarride, JE Okoh, A. Aryal, K. et al.

Source: Orphanet Journal of Rare Diseases. 5/6/2024, Vol. 19 Issue 1, p1-13. 13p.

Intravitreal Injection Rates for Neovascular Age-Related Macular Degeneration in Australia During the 2020 COVID-19 Lockdowns.

Authors: Phakey, Sachin Hall, Anthony J Lim, Lyndell L

Source: Ophthalmic Epidemiology. Feb2024, Vol. 31 Issue 1, p94-97. 4p.